熱門資訊> 正文
选择医疗任命新首席执行官,宣布执行领导层变动
2025-09-03 05:40
- Select Medical Holdings (NYSE:SEM) said on Tuesday it has appointed Thomas P. Mullin as CEO, effective immediately.
- Mullin succeeds David S. Chernow, who becomes Vice Chairman of the board after serving as CEO since 2014.
- Mullin, a 17-year company veteran, most recently served as co-president overseeing 140 hospitals in the company’s critical illness recovery and inpatient rehabilitation divisions.
- Other leadership changes include the appointment of John A. Saich as sole President and John F. Duggan as Executive Vice President, General counsel and Secretary.
- Michael E. Tarvin will transition to Senior Executive Vice President of legal services.
- Source: Press Release
More on Select Medical
- Select Medical Holdings Corporation (SEM) Q2 2025 Earnings Call Transcript
- Select Medical: Despite A Change In The Regulatory Environment, This Prospect Is Worth Considering
- Select Medical reaffirms $5.3B–$5.5B 2025 revenue outlook as inpatient rehab expansion accelerates
- Select Medical GAAP EPS of $0.32 beats by $0.07, revenue of $1.34B misses by $10M
- Seeking Alpha’s Quant Rating on Select Medical
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。